Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes
用户k7g3AjDeE8DM
2个月前
99
10
已完结
1. 系统已在2025-08-01 15:24:06对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://www.acpjournals.org/doi/10.7326/ANNALS-24-00775
其他信息:
出版社: American College of Physicians
作者: Anum Saeed; Suresh R. Mulukutla; Floyd Thoma; Lara Lemon; Agnes Koczo; Steven Reis; Oscar Marroquin; Kevin Kip
全文下载地址: https://www.acpjournals.org/doi/pdf/10.7326/ANNALS-24-00775
